Equities

Zhejiang Jiuzhou Pharmaceutical Co Ltd

603456:SHH

Zhejiang Jiuzhou Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)14.87
  • Today's Change-0.80 / -5.11%
  • Shares traded31.78m
  • 1 Year change-45.99%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments3,079663753
Total Receivables, Net1,108822913
Total Inventory1,9592,0211,682
Prepaid expenses415430
Other current assets, total128433394
Total current assets6,3143,9933,772
Property, plant & equipment, net3,7223,1442,645
Goodwill, net11011170
Intangibles, net572517428
Long term investments122109101
Note receivable - long term2.225.999.76
Other long term assets------
Total assets10,8527,9137,040
LIABILITIES
Accounts payable917842640
Accrued expenses235210170
Notes payable/short-term debt280453843
Current portion long-term debt/capital leases142071.01
Other current liabilities, total210502431
Total current liabilities1,6572,2142,085
Total long term debt40195205
Total debt6967541,049
Deferred income tax10110677
Minority interest72750
Other liabilities, total16012797
Total liabilities2,3912,6172,463
SHAREHOLDERS EQUITY
Common stock899834833
Additional paid-in capital4,4992,0581,985
Retained earnings (accumulated deficit)3,1952,5201,807
Treasury stock - common(132)(113)(44)
Unrealized gain (loss)------
Other equity, total(0.64)(2.7)(3.63)
Total equity8,4615,2974,577
Total liabilities & shareholders' equity10,8527,9137,040
Total common shares outstanding894830830
Treasury shares - common primary issue5.554.322.41
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.